The Readout Loud

A podcast by STAT - Thursdays

Thursdays

Categories:

331 Episodes

  1. Episode 30: A fish oil epiphany, VC monopolies and ketamine clinics

    Published: 27/09/2018
  2. Episode 29: A Hong Kong heat-check, a $20 million wrist slap, and pharma's (other) diversity problem

    Published: 20/09/2018
  3. Episode 28: Founders' funds, doctors' disclosures, and the subtle art of beeping

    Published: 13/09/2018
  4. Episode 27: Live from Boston!

    Published: 06/09/2018
  5. Episode 26: FDA shows its teeth, biotech fish oil might be pointless, & treating McCain's cancer

    Published: 30/08/2018
  6. Episode 25: A genome-editing first, Trump on Wall Street, and biotech red flags

    Published: 23/08/2018
  7. Episode 24: A lesson in startup jargon, pharma's bare Alzheimer's cupboard, and the cost of CAR-T

    Published: 16/08/2018
  8. Episode 23: Congressional insider trading, PETA and fake meat, & doctors vs. fund managers

    Published: 09/08/2018
  9. Episode 22: Biotech's battle for talent, Sanofi's second act, and climbing Mt. Everest

    Published: 02/08/2018
  10. Episode 21 - A debatable Alzheimer's breakthrough, Gilead's golden age, and "robust" data

    Published: 26/07/2018
  11. Episode 20 - CRISPR freakouts, drug prices meet elections, and a busy earnings season

    Published: 19/07/2018
  12. Episode 19: Trump's telephonic prowess, Biogen's mysterious future, & the rise of 'hypelines'

    Published: 12/07/2018
  13. Episode 18: Biotech's six-month review, how to become a day trader and soul-searching analysts

    Published: 05/07/2018
  14. Episode 17: A friendly FDA, biosimilar awkwardness and how to sell drugs in China

    Published: 28/06/2018
  15. Episode 16: Sarepta's big week, Theranos' legal woes and parsing AI hype

    Published: 21/06/2018
  16. Episode 15: Problematic parties, Nitpicking NASH, and an opioid documentary from STAT

    Published: 14/06/2018
  17. Episode 14: Twitter vitriol, biotech jargon, and the plight of the CEO

    Published: 07/06/2018
  18. Episode 13: Spending millions on fatty liver disease. Overhyped cancer drugs. Who goes to BIO?

    Published: 31/05/2018
  19. Episode 12: Ebola should worry you, again; 23andMe's World Cup whoops; Don't drink sunscreen

    Published: 24/05/2018
  20. Episode 11: Inside the Theranos collapse, Valeant's latest legal lumps, and a few biotech hot takes

    Published: 17/05/2018

16 / 17

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Visit the podcast's native language site